Hemophilia is a hereditary genetic disorder which impairs body’s ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, coagulation does not occur. Of the two types of hemophilia, hemophilia A has higher prevalence compared to the other variant hemophilia B. . Acquired hemophilia is a rare non genetic form of hemophilia in which autoantibodies develop against the plasma coagulation factor. The development of novel coagulating factors and technological advancements are driving the growth of this market. Lack of available medicines, awareness of this disease and high cost of treatment are the major restraining factors in this market. The advancements in gene therapy and approaching approval of drugs for treatment of hemophilia provide growth opportunities in this market.
Global hemophilia treatment type market analysis
On the basis of type of hemophilia, this market can be classified into hemophilia A and hemophilia B. The market for hemophilia A is largest due to high prevalence rate of this variant of hemophilia.
Global hemophilia treatment medicine market analysis
On the basis of medicines used for treating hemophilia, this market is classified into octocogalfa, nonacogalfa, desmopressin and others. Many market players are focusing on gene therapy and there are many drugs in pipeline awaiting approval.
Hemophilia treatment geography market analysis
On the basis of geography, this market is classified into North America, Europe, Asia-Pacific and rest of the world (RoW). Presently, North America is the major contributor to the revenues generated in this market. Due to increasing medical tourism, Asia-Pacific region is expected to emerge as the largest market for hemophilia treatment market.
The major market players contributing to this market are Bayer AG, Pfizer Inc., Baxter International Inc. Biogen Idec, Inc. and Swedish Orphan Biovitrum AB. The companies are focusing on approval of their drugs that are in the pipeline for treating hemophilia.
High level analysis
The report analyzes global hemophilia treatment market using Porter’s five forces model. Porter’s model explains the constitution of industry and helps in analyzing the bargaining power of buyers and suppliers. In this market, high initial capital investment may be a threat for new entrants.
Key market Segments
The global hemophilia market is classified based on its types, medicines used and geography.
Market by Type
Market by Medicines
Market by Geography
SIMILAR MARKET STUDIES
Summary Apollo Hospitals Enterprise Limited (Apollo Hospitals) is a healthcare service provider that offers a range of healthcare services and pharmaceutical products. It operates one of the largest healthcare networks in Asia. It offers healthcare at the patient’s doorstep, clinical and diagnostic services, medical business process outsourcing, third party administration services ...
March 2016 | $250 | View Details >>
Malignant Glioma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Glioma. Report includes an overview of trial numbers and ...
July 2016 | $2500 | View Details >>
Notes: Production, means the output of Thrombectomy Devices Revenue, means the sales value of Thrombectomy Devices This report studies Thrombectomy Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering ...
December 2016 | $2900 | View Details >>
Aptose Biosciences Inc. - Product Pipeline Review - 2015 Summary Global Markets Directs, Aptose Biosciences Inc. - Product Pipeline Review - 2015, provides an overview of the Aptose Biosciences Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Aptose Biosciences Inc.s, complete with comparative ...
September 2015 | $1500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research